-
Dangote to launch $16bn refinery in Kenya
-
Nagoya mayor says sorry for Asian Games 'inconveniences'
-
North Korean leader 'extremely obese': Seoul spy agency
-
G20 trade officials meet under shadow of tariffs, overcapacity
-
Yankees and pope-backed White Sox start MLB playoffs with wins
-
India's fat dog vote goes viral
-
Malaysia's ex-PM Mahathir in hospital for observation
-
Asian Games crowds in spotlight as 998 see hosts in 50,000 stadium
-
'No limits': Marathon world record holder Sawe chasing history
-
The eight stadiums for the 2027 Rugby World Cup
-
Countdown begins to biggest-ever Rugby World Cup
-
Thieves swipe drugs under nose of Fiji police, swap with flour
-
Bangladesh women lose ground after quota reform
-
South Korea demands North apologise for DMZ mine blasts
-
Vietnam admits 'differing opinions' on Hanoi development
-
In Nepal's flood zone, teachers mourn students who never returned
-
Stocks temper gains as oil pares heavy losses, US data in focus
-
US Supreme Court lifts limits on third-country deportations
-
New Zealand denies breaching climate commitments to EU
-
Antonelli eager to 're-establish order' as F1 returns to Malaysia
-
Albert becomes youngest US scorer in 4-2 win over Chile
-
Paw-fect candidate: Australia finds new koala rescue dog
-
Pirate island's plunging population shows Greece's demographic decline
-
One third of world population exposed to harmful air pollution: monitor
-
With elections ahead, Latvia's Russian-speakers reject Moscow's help
-
North Korea denies South's claim it was apparently behind DMZ mine blasts
-
Brazil football clubs face massive sponsorship blow from betting ban
-
West Bank's violent settlers part of a new generation fuelled by ideology
-
ChatGPT maker wants to be the App Store for AI as safety concerns grow
-
US-led coalition ends mission in Iraq
-
Women fight fires and sexism in Indonesian Borneo
-
Pope-backed White Sox join Braves with MLB playoff wins
-
Forsling's OT blast lifts Florida over Carolina in NHL opener
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 30
-
Alpha Growth Management Opens Rep Office in Japan
-
Guardian Metal Resources PLC Announces Total Voting Rights
-
NBA close to picking new $12-13bn Vegas team owners: report
-
Hurricane Polo sweeps over Mexico's Pacific coast, heads inland
-
LA28 Olympics torch relay to visit all 50 states
-
Grynspan pulls ahead in race to lead UN: diplomat
-
Spain brush aside Croatia in Nations League, England down Czechs
-
Trump touts AI boss pledge to self-regulate
-
Trump hails 'morally binding' AI self-regulation pledge
-
Oil down, but stocks lower as bond yields rise
-
Yamal inspires Spain to Croatia romp on World Cup homecoming
-
England break down stubborn Czechs to claim first Nations League win
-
UN to hold fourth informal poll of secretary-general candidates
-
UN Security Council extends Haiti anti-gang force by 6 months
-
Who are the Emiratis behind crisis-hit Manchester City?
-
Manchester City guilty of Premier League charges: What comes next?
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
B.Torres--AT